Asthma and COPD (chronic obstructive pulmonary disease) are a growing major health burden, which, despite improvements in disease management, still require new effective treatments. As our understanding of the cellular and molecular processes which govern respiratory diseases improves, the range of potential therapeutic targets increase. PI 3-kinases (phosphoinositide 3-kinases) are a family of closely related enzymes, which play pivotal roles in a diverse array of cellular mechanisms. In the present paper, we review the evidence for PI 3-kinase involvement in various cellular processes underlying asthma and COPD generated through inhibitor studies and gene-targeting approaches, and discuss the prospects for PI 3-kinase inhibition as a future therapeutic strategy for the treatment of respiratory disease.
Skip Nav Destination
Conference Article| April 01 2004
PI 3-kinase inhibition: a therapeutic target for respiratory disease
Biochem Soc Trans (2004) 32 (2): 378–382.
- Views Icon Views
- Share Icon Share
P.M. Finan, M.J. Thomas; PI 3-kinase inhibition: a therapeutic target for respiratory disease. Biochem Soc Trans 1 April 2004; 32 (2): 378–382. doi: https://doi.org/10.1042/bst0320378
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article